ABCLAbCellera Biologics Inc.May 12, 2026Q1 2026
Read transcript →AbCellera Biologics Inc. (ABCL) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$5.37
+1.61%
Mkt Cap $1.75B
ABCLAbCellera Biologics Inc.May 12, 2026ABCLAbCellera Biologics Inc.Feb 24, 2026Q4 2025
Read transcript →ABCLAbCellera Biologics Inc.Nov 7, 2025Q3 2025
Read transcript →ABCLAbCellera Biologics Inc.Aug 7, 2025Q2 2025
Read transcript →ABCLAbCellera Biologics Inc.May 8, 2025Q1 2025
Read transcript →ABCLAbCellera Biologics Inc.Feb 27, 2025Q4 2024
Read transcript →ABCLAbCellera Biologics Inc.Nov 4, 2024Q3 2024
Read transcript →ABCLAbCellera Biologics Inc.Aug 6, 2024Q2 2024
Read transcript →ABCLAbCellera Biologics Inc.May 7, 2024Q1 2024
Read transcript →ABCLAbCellera Biologics Inc.Feb 20, 2024Q4 2023
Read transcript →ABCLAbCellera Biologics Inc.Nov 2, 2023Q3 2023
Read transcript →ABCLAbCellera Biologics Inc.Aug 3, 2023Q2 2023
Read transcript →ABCLAbCellera Biologics Inc.May 4, 2023Q1 2023
Read transcript →ABCLAbCellera Biologics Inc.Feb 21, 2023Q4 2022
Read transcript →ABCLAbCellera Biologics Inc.Nov 8, 2022Q3 2022
Read transcript →ABCLAbCellera Biologics Inc.Aug 10, 2022Q2 2022
Read transcript →ABCLAbCellera Biologics Inc.May 10, 2022Q1 2022
Read transcript →ABCLAbCellera Biologics Inc.Feb 24, 2022Q4 2021
Read transcript →ABCLAbCellera Biologics Inc.Nov 9, 2021Q3 2021
Read transcript →ABCLAbCellera Biologics Inc.Aug 12, 2021Q2 2021
Read transcript →ABCLAbCellera Biologics Inc.May 13, 2021Q1 2021
Read transcript →ABCLAbCellera Biologics Inc.Mar 29, 2021Q4 2020
Read transcript →